Table 6 |
|||||||||
|
H. glycines probesets homologous to C. elegans genes that are involved in dauer metabolism |
|||||||||
|
H. glycines probeset |
EST |
Contig length |
E-value* |
Identity (%) |
C. elegans gene |
Descriptor C. elegans gene |
InfJ2/egg† |
InfJ2/parJ2† |
InfJ2/female† |
|
|
|||||||||
|
Phosphofructokinase |
|||||||||
|
HgAffx.14924.1.S1_at |
6 |
670 |
2.4e-77 |
72.1 |
Y110A7A.6a |
Phosphofructokinase |
Up |
Up |
|
|
Citrate cycle |
|||||||||
|
HgAffx.18932.1.S1_at |
7 |
882 |
1.4e-113 |
76.8 |
T05H10.6a |
Pyruvate dehydrogenase E1 alpha subunit |
Down |
||
|
HgAffx.22652.1.S1_at |
16 |
488 |
5.8e-73 |
83.9 |
T20G5.2 |
Citrate synthase |
Up |
||
|
HgAffx.17812.1.S1_at |
4 |
493 |
8.1e-56 |
76.1 |
T20G5.2 |
Citrate synthase |
Up |
||
|
HgAffx.6732.1.S1_at |
1 |
631 |
3.9e-74 |
71.3 |
C37E2.1 |
Isocitrate dehydrogenase |
Down |
Up |
Up |
|
HgAffx.22639.1.S1_at |
6 |
489 |
6.6e-45 |
62.1 |
C34F6.8 |
Isocitrate and isopropylmalate dehydrogenases |
Up |
Up |
Up |
|
HgAffx.15376.1.S1_at |
1 |
435 |
3.8e-38 |
75.2 |
C30F12.7 |
Isocitrate dehydrogenase |
Up |
||
|
HgAffx.13764.1.S1_at |
1 |
400 |
9.2e-30 |
60.7 |
C05G5.4 |
Succinyl-CoA synthetase |
Up |
Up |
Up |
|
HgAffx.23207.1.A1_at |
4 |
604 |
3.9e-31 |
46.4 |
F25H2.5 |
Nucleoside diphosphate kinase |
Up |
Down |
Down |
|
HgAffx.24228.1.S1_at |
17 |
790 |
1.2e-59 |
75.4 |
F25H2.5 |
Nucleoside diphosphate kinase |
Down |
||
|
HgAffx.14699.1.S1_at |
4 |
666 |
2.5e-82 |
71 |
C03G5.1 |
Succinate dehydrogenase subunit |
Up |
||
|
HgAffx.23633.1.S1_at |
3 |
624 |
8.8e-75 |
77.6 |
F42A8.2 |
Succinate dehydrogenase |
Up |
Up |
|
|
HgAffx.18264.1.S1_at |
1 |
472 |
5.2e-50 |
76.4 |
C03G5.1 |
Succinate dehydrogenase subunit |
Up |
||
|
HgAffx.23633.2.S1_at |
1 |
406 |
1.7e-33 |
82 |
F42A8.2 |
Succinate dehydrogenase |
Up |
Up |
|
|
HgAffx.17082.1.S1_at |
1 |
375 |
4.4e-31 |
51.1 |
T07C4.7 |
Succinate dehydrogenase cytochrome b chain |
Up |
Up |
|
|
HgAffx.2164.1.A1_at |
2 |
738 |
8.4e-82 |
76 |
H14A12.2a |
Fumarase |
|||
|
HgAffx.2164.1.S1_at |
2 |
738 |
8.4e-82 |
76 |
H14A12.2a |
Fumarase |
|||
|
HgAffx.17587.1.S1_at |
1 |
488 |
4.2e-45 |
62.7 |
F20H11.3 |
Malate dehydrogenase |
Up |
Up |
|
|
HgAffx.14431.1.S1_at |
3 |
551 |
1.0e-57 |
67.6 |
F20H11.3 |
Malate dehydrogenase |
Up |
||
|
Glyoxylate cycle |
|||||||||
|
HgAffx.22652.1.S1_at |
16 |
488 |
5.8e-73 |
83.9 |
T20G5.2 |
Citrate synthase |
Up |
||
|
HgAffx.17812.1.S1_at |
4 |
493 |
8.1e-56 |
76.1 |
T20G5.2 |
Citrate synthase |
Up |
||
|
HgAffx.21758.1.S1_at |
2 |
402 |
2.9e-37 |
77.7 |
C05E4.9a |
Isocitrate lyase |
|||
|
HgAffx.17587.1.S1_at |
1 |
488 |
4.2e-45 |
62.7 |
F20H11.3 |
Malate dehydrogenase |
Up |
Up |
|
|
HgAffx.14431.1.S1_at |
3 |
551 |
1.0e-57 |
67.6 |
F20H11.3 |
Malate dehydrogenase |
Up |
||
|
SMA and DAF proteins |
|||||||||
|
HgAffx.22024.1.S1_at |
5 |
772 |
1.6e-78 |
74.2 |
ZK370.2 |
SMA-2 |
|||
|
HgAffx.17831.1.S1_at |
1 |
423 |
1.1e-41 |
67.0 |
R13F6.9 |
SMA-3 |
Down |
||
|
HgAffx.19781.1.S1_at |
1 |
463 |
3.7e-49 |
69.9 |
R12B2.1 |
SMA-4 |
Down |
Up |
Up |
|
HgAffx.16166.1.S1_at |
1 |
475 |
3.9e-26 |
50.0 |
C32D5.2 |
SMA-6 |
Down |
||
|
HgAffx.10752.1.S1_at |
1 |
651 |
9.5e-30 |
44.7 |
B0240.3 |
DAF-11 |
Up |
||
|
HgAffx.8385.1.S1_at |
1 |
410 |
4.5e-21 |
77.5 |
R13H8.1a |
DAF-16 |
|||
|
HgAffx.21332.1.S1_at |
36 |
2325 |
9.0e-280 |
78.6 |
C47E8.5 |
DAF-21 (Heatshock protein 90) |
Down |
||
|
Superoxide dismutase |
|||||||||
|
HgAffx.23145.1.S1_at |
9 |
691 |
1.1e-51 |
60.7 |
C15F1.7a |
Superoxide dismutase 1 |
Down |
||
|
HgAffx.18049.1.S1_at |
3 |
698 |
2.2e-38 |
60.9 |
ZK430.3 |
Superoxide dismutase 5 |
Down |
Down |
Down |
|
HgAffx.7684.1.S1_at |
2 |
538 |
1.7e-55 |
67.3 |
F10D11.1 |
Superoxide dismutase 2 |
Down |
||
|
HgAffx.18572.1.S1_at |
2 |
522 |
6.5e-24 |
41.6 |
ZK430.3 |
Superoxide dismutase 5 |
Down |
||
|
Catalase |
|||||||||
|
HgAffx.18847.1.S1_at |
1 |
485 |
6.4e-67 |
81.9 |
Y54G11A.5 |
Catalase 2 |
Up |
Down |
|
|
HgAffx.9380.1.S1_at |
2 |
756 |
1.2e-57 |
64.6 |
Y54G11A.13 |
Catalase 3 |
Down |
||
|
|
|||||||||
|
*Threshold 1e-20. †Differential expression (FDR 5%) where indicated and expression level of probeset in infective J2 relative to other stage. |
|||||||||
|
Elling et al. Genome Biology 2007 8:R211 doi:10.1186/gb-2007-8-10-r211 |
|||||||||
